Hyperprolactinemia Clinical Trial
Official title:
Spontaneous Spinal Cerebrospinal Fluid Leaks and Intracranial Hypotension
Previous research has identified spontaneous cerebral spinal fluid leakage as a cause for spontaneous intracranial hypotension, leading to positional headache patterns. Typical magnetic resonance imaging findings include subdural fluid collections, enhancement of pachymenginges, engorgement of venous structures, pituitary hyperemia, and sagging of the brain (SEEPS). Because pituitary hyperemia has been documented in cases of spontaneous cerebral spinal fluid leakage and is known to mimic a pituitary tumor or hyperplasia, the investigators would like to like to assess the clinical manifestations and neuroimaging abnormalities of SIH patients with regard to the pituitary gland. Specifically, the investigators are looking to analyze the compression of the pituitary stalk and conduct a systemic evaluation of pituitary function in SIH patients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03569787 -
Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
|
||
Completed |
NCT02098668 -
Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
|
N/A | |
Completed |
NCT03038308 -
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT00541554 -
Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
|
Phase 4 | |
Completed |
NCT01270711 -
Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)
|
N/A | |
Completed |
NCT02956447 -
Administration of Kisspeptin in Patients With Hyperprolactinemia
|
Phase 2 | |
Recruiting |
NCT05033119 -
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
|
||
Completed |
NCT06326840 -
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
|
N/A | |
Withdrawn |
NCT00699530 -
Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
|
N/A | |
Not yet recruiting |
NCT00315081 -
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
|
Phase 3 | |
Recruiting |
NCT04746313 -
Prevalence of Hyperprolactinemia in Systemic Scleroderma
|
||
Terminated |
NCT04146389 -
Hyperprolactinemia and Adrenal Steroidogenesis
|
||
Recruiting |
NCT00914823 -
Kisspeptin Administration in the Adult
|
Phase 1 | |
Completed |
NCT01852331 -
Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
|
Phase 2 | |
Completed |
NCT01338298 -
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
|
N/A | |
Completed |
NCT01052948 -
The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events
|
N/A | |
Completed |
NCT00436111 -
Characterization of Macroprolactinemia
|
N/A | |
Active, not recruiting |
NCT04439747 -
Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT01742390 -
A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
|
Phase 4 | |
Completed |
NCT00625950 -
Endometriosis Patients Undergoing Quinagolide Treatment
|
Phase 4 |